IsoClear uniquely focuses on detecting types of protein biomarkers that are directly related to disease

Our proprietary IsoClear platform is tunable to detect underlying cancer biology by measuring changes in the structure of proteins. Adding information on the origin of a biomarker to the current measurement of concentration can add accuracy, specificity, and clarity to cancer diagnostics.

Clinical Applications